Certain OTC Drug Monograph Claims May Be Structure/Function Claims - FDA
This article was originally published in The Tan Sheet
Executive Summary
Some OTC drug monograph claims may be acceptable dietary supplement structure/function claims, FDA concludes in the final rule on supplement claims criteria published in the Jan. 6 Federal Register. However, others would be disease claims if used on supplement products, the agency adds.
You may also be interested in...
OTC/Supplement Combinations "Serious Concern" For FDA
The appropriateness of combination products containing OTC drug and dietary supplement ingredients is under review at FDA. In the interim, the agency is discouraging firms from marketing such items.
OTC/Supplement Combinations "Serious Concern" For FDA
The appropriateness of combination products containing OTC drug and dietary supplement ingredients is under review at FDA. In the interim, the agency is discouraging firms from marketing such items.
OTC/Supplement Combinations "Serious Concern" For FDA
The appropriateness of combination products containing OTC drug and dietary supplement ingredients is under review at FDA. In the interim, the agency is discouraging firms from marketing such items.